1. Home
  2. SNY vs AMAT Comparison

SNY vs AMAT Comparison

Compare SNY & AMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • AMAT
  • Stock Information
  • Founded
  • SNY 1994
  • AMAT 1967
  • Country
  • SNY France
  • AMAT United States
  • Employees
  • SNY N/A
  • AMAT N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • AMAT Semiconductors
  • Sector
  • SNY Health Care
  • AMAT Technology
  • Exchange
  • SNY Nasdaq
  • AMAT Nasdaq
  • Market Cap
  • SNY 120.2B
  • AMAT 151.9B
  • IPO Year
  • SNY N/A
  • AMAT N/A
  • Fundamental
  • Price
  • SNY $48.28
  • AMAT $174.88
  • Analyst Decision
  • SNY Buy
  • AMAT Buy
  • Analyst Count
  • SNY 2
  • AMAT 22
  • Target Price
  • SNY $57.50
  • AMAT $218.68
  • AVG Volume (30 Days)
  • SNY 2.2M
  • AMAT 6.9M
  • Earning Date
  • SNY 10-25-2024
  • AMAT 11-14-2024
  • Dividend Yield
  • SNY 4.22%
  • AMAT 0.91%
  • EPS Growth
  • SNY N/A
  • AMAT 6.17
  • EPS
  • SNY 4.00
  • AMAT 8.61
  • Revenue
  • SNY $54,031,898,261.00
  • AMAT $27,176,000,000.00
  • Revenue This Year
  • SNY $3.18
  • AMAT $13.17
  • Revenue Next Year
  • SNY $6.67
  • AMAT $8.61
  • P/E Ratio
  • SNY $24.16
  • AMAT $20.31
  • Revenue Growth
  • SNY 6.01
  • AMAT 2.49
  • 52 Week Low
  • SNY $45.22
  • AMAT $144.57
  • 52 Week High
  • SNY $58.97
  • AMAT $255.89
  • Technical
  • Relative Strength Index (RSI)
  • SNY 30.07
  • AMAT 41.82
  • Support Level
  • SNY $47.56
  • AMAT $167.06
  • Resistance Level
  • SNY $48.67
  • AMAT $177.07
  • Average True Range (ATR)
  • SNY 0.69
  • AMAT 4.15
  • MACD
  • SNY -0.16
  • AMAT -0.90
  • Stochastic Oscillator
  • SNY 15.05
  • AMAT 29.22

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About AMAT Applied Materials Inc.

Applied Materials is the largest semiconductor wafer fabrication equipment, or WFE, manufacturer in the world. Applied Materials has a broad portfolio spanning nearly every corner of the WFE ecosystem. Specifically, Applied Materials holds a market share leadership position in deposition, which entails the layering of new materials on semiconductor wafers. It is more exposed to general-purpose logic chips made at integrated device manufacturers and foundries. It counts the largest chipmakers in the world as customers, including TSMC, Intel, and Samsung.

Share on Social Networks: